ORPHA:590539
Isolated melanotic schwannoma
Also known as: Isolated melanocytic schwannoma
Publications
0
Trials
0
Interventional, condition-specific
Researchers
0
Distinct authors in sample
Gene link
—
Readiness
0/6
Stages with a signal
Clinical definition (Orphanet)
A rare nervous system tumor characterized by cells phenotypically representing Schwann cells but containing melanosomes and expressing melanoma markers. The entity occurs as a non-psammomatous (typically affecting spinal nerves) or a psammomatous (also involving nerves of the intestinal tract and heart) variant. About 50% of psammomatous tumors are associated with Carney complex. Slightly over 10% of melanotic schwannomas follow a malignant course.
How rare: How common this is has not been clearly measured.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
0/6 stages with a signal
Search queries returned nothing — this usually means a naming mismatch, not proof that nothing exists.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteratureNot checked
Query returned nothing — not evidence of absence Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialNot checked
Broken query — trial zero not trusted
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
0
We found no papers under this exact name — work may still exist under another label.
0 in the last 10 years · low confidence
Phrase hits: 0 · MeSH hits: 0
Who's working on it?
0
Distinct author names in 0 sampled papers.
Who's working on it?
No author names could be extracted from the sampled publications. Try the Europe PMC query in “How we counted this,” or contact an umbrella rare-disease organisation for researcher referrals.
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present). 64 trials are registered for schwannoma, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 27 July 2026
No matched interventional trials. This is true for 73% of diseases in the trials denominator (5114 of 7003). Here are the researchers publishing on it.
low confidence
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
64 interventional trials matched schwannoma, the broader category — listed below. Those studies are not counted in the condition-specific total.
Broader category: schwannoma
64
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT05578560·RECRUITING·The Use of Virtual Reality in Rehabilitation in Patients After Vestibular Schwannoma Surgery.
Conditions: Acute Peripheral Vestibulopathy Following Surgical Procedure·Matched via name phrase
- NCT06112509·RECRUITING·Evolution of Vestibular Function After Treatment of a Vestibular Schwannoma by Gamma-knife Radio-surgery
Conditions: Vestibular Schwannoma · Neurinoma, Acoustic · Acoustic Neuroma·Matched via name phrase
- NCT06572475·RECRUITING·USPIO Enhanced MR Imaging in CNS Tumours (UMIC)
Conditions: Vestibular Schwannoma · Glioma, Astrocytic·Matched via name phrase
- NCT07708285·NOT YET RECRUITING·Luvometinib in Combination With Serplulimab for NF2-Related Tumors
Conditions: NF2-related Schwannomatosis · NF2 · Neurofibromatosis Type 2 · Vestibular Schwannoma·Matched via name phrase
- NCT04278118·RECRUITING·Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study
Conditions: Grade I Meningioma · Grade II Meningioma · Grade III Meningioma · Intracranial Neoplasm·Matched via name phrase
- NCT07267910·ENROLLING BY INVITATION·Measuring Vestibular Organ Function With Weak Alternating Current Stimulation
Conditions: Vestibular Disorder · Vestibular Schwannoma · Vestibular Neuritis·Matched via name phrase
- NCT07364955·RECRUITING·Vestibular Rehabilitation Protocol in Unilateral Vestibular Schwannoma
Conditions: Vestibular Schwannoma · Vestibular Schwannomas·Matched via name phrase
- NCT07707947·NOT YET RECRUITING·Selumetinib for NF2-Related Schwannomatosis
Conditions: Neurofibromatosis Type 2 · NF2 · NF2-related Schwannomatosis · Meningioma·Matched via name phrase
- NCT04374305·RECRUITING·Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
Conditions: Neurofibromatosis Type 2 · Vestibular Schwannoma · Non-vestibular Schwannoma · Meningioma·Matched via name phrase
- NCT04859335·RECRUITING·Evolution of Balance and Vestibular Function in Patients Treated With Gammaknife Radiosurgery for Vestibular Schwannoma
Conditions: Vestibular Schwannoma·Matched via name phrase
- NCT05622344·RECRUITING·StableEyes With Active Neurofeedback
Conditions: Vestibular Disorder · Vestibular Schwannoma · Space Motion Sickness · Motion Sickness·Matched via name phrase
- NCT07713745·NOT YET RECRUITING·Platform Research for Innovative Medicines in NF2-SWN (PRIME-NF2)
Conditions: Neurofibromatosis Type 2 · Vestibular Schwannoma · Non-vestibular Schwannoma · Meningioma·Matched via name phrase
- NCT07116811·NOT YET RECRUITING·Steroids for Facial Nerve Function Protection in Post-surgical Vestibular Schwannoma Patients
Conditions: Vestibular Schwannoma · Facial Nerve Paralysis·Matched via name phrase
- NCT06660082·RECRUITING·Early Rehabilitation Using Head Impulse Test for Acute Vestibular Deficit
Conditions: Vestibular Schwannoma · Unilateral Vestibular Deficit·Matched via name phrase
- NCT05702749·RECRUITING·Evaluating Pre-Treatment Vestibular Physical Therapy Rehab for Patients With Vestibular Schwannomas
Conditions: Vestibular Schwannoma·Matched via name phrase
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Isolated melanotic schwannoma" OR "Isolated melanocytic schwannoma"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Isolated melanotic schwannoma" OR "Isolated melanocytic schwannoma" OR "melanotic neurilemmoma"
Recall-expansion terms: melanotic neurilemmoma
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"schwannoma"
Query health: broken — strategies attempted: phrase, recall-expansion; with hits: none
Parent literature probe: central nervous system sarcoma (MONDO:0002217) — 54 hits
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- Zero publications but parent term central nervous system sarcoma has 54 — literature likely indexed under a broader name
Ingested 2026-07-27T18:48:36.981Z · excluded from neglect metrics
